ScoreWhy is Aspira Pathlab & Diagnostics Ltd ?
1
Healthy long term growth as Operating profit has grown by an annual rate 32.87%
2
With a growth in Net Profit of 85.86%, the company declared Outstanding results in Sep 25
- The company has declared positive results for the last 6 consecutive quarters
- OPERATING CF(Y) Highest at Rs 1.88 Cr
- ROCE(HY) Highest at 21.54%
- NET SALES(Q) At Rs 8.09 cr has Grown at 30.91%
3
With ROE of 23.6, it has a Very Attractive valuation with a 4.9 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -8.84%, its profits have risen by 368% ; the PEG ratio of the company is 0
4
Majority shareholders : Non Institution
5
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -8.84% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Aspira Pathlab for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Aspira Pathlab
-16.98%
-0.17
51.40%
Sensex
-4.3%
0.44
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.34%
EBIT Growth (5y)
18.74%
EBIT to Interest (avg)
1.07
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
1.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-5.51%
ROE (avg)
18.89%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
55
Price to Book Value
4.56
EV to EBIT
49.62
EV to EBITDA
23.34
EV to Capital Employed
4.28
EV to Sales
2.76
PEG Ratio
0.61
Dividend Yield
NA
ROCE (Latest)
21.20%
ROE (Latest)
10.19%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
ROCE(HY)
Highest at 21.54%
-12What is not working for the Company
PAT(Q)
At Rs -1.56 cr has Fallen at -510.5%
NET SALES(Q)
Lowest at Rs 5.12 cr
PBDIT(Q)
Lowest at Rs -1.21 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at -23.63%
PBT LESS OI(Q)
Lowest at Rs -1.69 cr.
EPS(Q)
Lowest at Rs -1.52
Loading Valuation Snapshot...
Here's what is not working for Aspira Pathlab
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -1.69 cr has Fallen at -682.76%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -1.56 cr has Fallen at -510.5%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 5.12 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 5.12 cr has Grown at -5.36%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -1.21 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at -23.63%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -1.69 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs -1.52
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
